Enliven Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Enliven Therapeutics, Inc.
CIK #0001672619
EDGAR Form CIK 2011 - 2023
10-K [0001672619]
10-Q [0001672619]
3 [0001672619]
4 [0001672619]
8-K [0001672619]
D [0001672619]
SC 13D [0001672619]
SC 13G [0001672619]
Form 13D/13G Filer Form 13D/13G Subject Filed
FMR LLC Enliven Therapeutics Inc [2023-05-10]
Fairmount Funds Management LLC Enliven Therapeutics Inc [2023-04-27]
Commodore Capital LP Enliven Therapeutics Inc [2023-04-24]
Venrock Healthcare Capital Partners III LP Enliven Therapeutics Inc [2023-03-13]
5AM Ventures VI LP Enliven Therapeutics Inc [2023-03-06]
Citadel Advisors LLC Enliven Therapeutics Inc [2023-03-06]
OrbiMed Advisors LLC Enliven Therapeutics Inc [2023-02-28]
Commodore Capital LP Imara Inc [2022-10-24]
RA Capital Management LP Imara Inc [2022-10-24]
BML Investment Partners LP Imara Inc [2022-04-14]
View All
Form 3/4/5 Subject 2011 - 2023
Enliven Therapeutics, Inc.
Gupta Rishi
OrbiMed Genesis GP LLC
OrbiMed Advisors LLC
OrbiMed Capital GP VII LLC
Lyssikatos Joseph P
Hohl Benjamin
Ballal Rahul D.
Bauer Jake
Derynck Mika K
View All
Terms | Privacy | Guide
tony@aum13f.com